Average Co-Inventor Count = 2.95
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Nec Corporation (8 from 35,670 patents)
2. Kochi University (6 from 50 patents)
3. Cytlimic Inc. (5 from 8 patents)
4. Osaka University (1 from 987 patents)
5. Ehime University (45 patents)
6. National University Corporation Kochi University (0 patent)
13 patents:
1. 12448413 - HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen presenting cell
2. 11618770 - MUC1-derived peptide, and pharmaceutical composition for treatment or prevention of cancer, immunity-inducing agent and method for manufacturing antigen presenting cell using same
3. 11304997 - HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen-presenting cell
4. 10875900 - Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells
5. 10590179 - Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells
6. 10537626 - HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen presenting cell
7. 10526388 - Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using the same, immunity inducer, and method for producing antigen-presenting cells
8. 9724403 - Therapeutic agent for cancer
9. 9353151 - HLA-binding peptide, and DNA fragment and recombinant vector coding for said HLA-binding peptide
10. 9045531 - HLA-binding peptide, precursor thereof, and DNA fragment and recombinant vector coding for said HLA-binding peptide
11. 9045556 - Therapeutic agent for cancer
12. 8487076 - HLA-binding peptide, and DNA fragment and recombinant vector coding for said HLA-binding peptide
13. 8324345 - HLA-binding peptide, precursor thereof, DNA fragment and recombinant vector encoding the same